EUCTR2008-004626-17-IT
进行中（未招募）
不适用
Anti-inflammatory and Anti-platelet effect of Clopidogrel and Aspirin vs Aspirin alone in Symptomatic Polyvascular disease and in patients with multiple recurrent cardiovascular events. - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点2008年9月22日
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Polyvascular disease and in patients with multiple recurrent cardiovascular events.
- 发起方
- POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
- 状态
- 进行中（未招募）
- 最后更新
- 14年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Patients of both sexes, between 40 and 75 years of age and with symptomatic polyvascular disease or recurrent cardiovascular events will be included. In particular inclusion criteria include patients with established stable coronary artery disease (no
- •acute coronary events in the 6 months before study entry with one of the following condition: stable angina with documented multivessels coronary disease, history of multivessel percutaneous coronary intervention, history of multivessel coronary artery bypass grafting or previous MI) associated with peripheral disease (current intermittent claudication and ankle\-brachial index0,85 or history of intermittent claudication with previous leg amputation, reconstructive surgery , or angioplasty) or cerebrovascular disease ( a previous documented TIA or Stroke) and patients with more than two acute cardiovascular events ( examples: more than 2 MI,or 2 MI plus one TIA or stroke).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
排除标准
- •The major exclusion criteria include cronic treatment with oral anticoagulant and other antiplatelet drugs wich might rise the emorragic risk; intollerance/allergy to aspirin or clopidrogrel; platelet count \< 125 \>145 10 ^/L;
- •other exclusion criteria are inflammatory or infectious disease, malignancies, or immunologic or hematologic disorders.
结局指标
主要结局
未指定
相似试验
Unknown
3 期
Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular EventsPolyvascular DiseaseCardiovascular DiseaseNCT00775762Catholic University of the Sacred Heart213
进行中（未招募）
1 期
Assessment of platelet inhibitory response to clopidogrel when coadministered with a proton pump inhibitor - Plavix and PPI studyEUCTR2009-011543-40-GBPapworth Hospital72
招募中
3 期
Investigating the anti-inflammatory effect of colchicine in patients undergoing coronary artery bypass graftCoronary Artery Disease.Atherosclerotic heart disease of native coronary arteryI25.1IRCT20220907055908N1Semnan University of Medical Sciences90
已完成
3 期
Anti-inflammatory effect of platelet-rich plasma compared with Intraarticular corticosteroid in osteoarthritis knee: A randomized controlled trialTCTR20240728001Department of orthopedic, Phramongkutklao hospital80
尚未招募
不适用
Anti-inflammatory and immunomodulative effects of clarithromycin for severe septic patientssevere sepsisJPRN-UMIN000021476Inoue laboratory, Tokai University30